Loading clinical trials...
Loading clinical trials...
This trial is conducted in Europe and the United States of America (USA). The purpose of this study is to test whether insulin detemir is a safe and at least as effective alternative to insulin glargi...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novo Nordisk A/S
NCT05398783 · Metabolic Disorders, Cancer, and more
NCT07224321 · Type 1 Diabetes Mellitus
NCT07395050 · Stage 3 Type 1 Diabetes
NCT01399385 · Healthy, Obesity, and more
NCT07536516 · Diabetes Mellitus
Novo Nordisk Investigational Site
Anaheim, California
Novo Nordisk Investigational Site
Huntington Beach, California
Novo Nordisk Investigational Site
Inglewood, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions